title: Pediatric allergic rhinitis: current and future state of the art.
abstract: Allergic rhinitis (AR) is the most common cause of allergic disease in the pediatric population. This chronic condition impacts quality of life, exacerbates comorbid conditions, and results in a significant economic burden. With an accurate diagnosis, there are many available therapies to reduce the burden of AR. Options include allergen avoidance, pharmacotherapy, and immune modulation. This review provides a comprehensive discussion of the current and future state of the art in the treatment of pediatric AR.
authors.affiliation: Allergy and Asthma Associates of Southern California, Viejo, California 92691, USA. warnercarr@hotmail.com
authors.forename: Warner W
authors.initials: WW
authors.lastname: Carr
mesh_terms: D018926:Anti-Allergic Agents / Q000627:therapeutic use; D002648:Child; D003888:Desensitization, Immunologic; D006801:Humans; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy / Q000628:therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy / Q000628:therapy*
chemical_list: D018926:Anti-Allergic Agents